By Michele Maatouk
Date: Wednesday 07 Jan 2026
(Sharecast News) - IP Group slumped on Wednesday after it said portfolio company Pulmocide has decided to end the Phase 3 study of its opelconazole product for the treatment of invasive pulmonary aspergillosis (IPA).
| Ashmore jumps on exposure to Venezuelan debt | 05-Jan-2026 | ShareCast |
| Bridgepoint in exclusive talks to buy majority s... | 05-Jan-2026 | ShareCast |
| Oakley takes majority stake in GLAS | 05-Jan-2026 | ShareCast |
| Transaction in Own Shares | 02-Jan-2026 | ShareCast |
| Total Voting Rights | 02-Jan-2026 | ShareCast |
| Transaction in Own Shares | 09-Jan-2026 | 07:30 | RNS |
| Holding(s) in Company | 09-Jan-2026 | 07:05 | RNS |
| Transaction in Own Shares | 09-Jan-2026 | 07:00 | EQS Group |
| Director/PDMR Shareholding | 09-Jan-2026 | 07:00 | RNS |
| Holding(s) in Company | 09-Jan-2026 | 07:00 | RNS |
| Bridgepoint buys Interpath from HIG Capital in £... | 05-Jan-2026 | Times |
| Man Group makes a fresh play in the US with a $7... | 18-Dec-2014 | Telegraph |
| London mandate for Braveheart | 05-Dec-2014 | The Herald |
| Aberdeen Asset Management directors sell £14 mil... | 05-Dec-2014 | The Herald |
| Martin Gilbert cashes in on Aberdeen share rise | 05-Dec-2014 | The Scotsman |
| Questor :Aberdeen Asset Management | 03-Dec-2014 | Telegraph |
| Questor:Brewin Dolphin | 14-Oct-2014 | Telegraph |
| Questor:Plus500 | 18-Jul-2014 | Telegraph |
| Questor :Man Group | 11-Jun-2014 | Telegraph |
| Questor :Brewin Dolphin | 30-May-2014 | Telegraph |
| Price | 14,334.16 |
| Closing Price Change | -51.02 |
| % Change | -0.35 % |
| 08-Jan-26 Close | 14,334.16 |
You are here: research